Related references
Note: Only part of the references are listed.Structure-Based Design of Potent and Selective Inhibitors of the Metabolic Kinase PFKFB3
Scott Boyd et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
Targeting the Warburg Effect in cancer; relationships for 2-arylpyridazinones as inhibitors of the key glycolytic enzyme 6-phosphofructo-2-kinase/2,6-bisphosphatase 3 (PFKFB3)
Darby G. Brooke et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2014)
Quantification of frequent-hitter behavior based on historical high-throughput screening data
J. Willem M. Nissink et al.
FUTURE MEDICINAL CHEMISTRY (2014)
Stratified High-Throughput Screening Sets Enable Flexible Screening Strategies from a Single Plated Collection
J. Willem M. Nissink et al.
JOURNAL OF BIOMOLECULAR SCREENING (2014)
Assay Development for Identifying Inhibitors of the Mycobacterial FadD32 Activity
Segolene Galandrin et al.
JOURNAL OF BIOMOLECULAR SCREENING (2013)
Overview of the CCP4 suite and current developments
Martyn D. Winn et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2011)
Structure-Based Development of Small Molecule PFKFB3 Inhibitors: A Framework for Potential Cancer Therapeutic Agents Targeting the Warburg Effect
Minsuh Seo et al.
PLOS ONE (2011)
XDS
Wolfgang Kabsch
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY (2010)
New Substructure Filters for Removal of Pan Assay Interference Compounds (PAINS) from Screening Libraries and for Their Exclusion in Bioassays
Jonathan B. Baell et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Comparison of Nephelometric, UV-Spectroscopic, and HPLC Methods for High-Throughput Determination of Aqueous Drug Solubility in Microtiter Plates
Bettina Hoelke et al.
ANALYTICAL CHEMISTRY (2009)
Characterization and Optimization of a Red-Shifted Fluorescence Polarization ADP Detection Assay
Karen M. Kleman-Leyer et al.
ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES (2009)
ADP-Glo: A Bioluminescent and Homogeneous ADP Monitoring Assay for Kinases
Hicham Zegzouti et al.
ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES (2009)
Regulation of glucose metabolism by 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatases in cancer
Abdullah Yalcin et al.
EXPERIMENTAL AND MOLECULAR PATHOLOGY (2009)
Efficient Elimination of Nonstoichiometric Enzyme Inhibitors from HTS Hit Lists
Michael Habig et al.
JOURNAL OF BIOMOLECULAR SCREENING (2009)
Imaging of tumor glucose utilization with positron emission tomography
Andrea Buerkle et al.
CANCER AND METASTASIS REVIEWS (2008)
Small-molecule inhibition of 6-phosphofructo-2-kinase activity suppresses glycolytic flux and tumor growth
Brian Clem et al.
MOLECULAR CANCER THERAPEUTICS (2008)
Phaser crystallographic software
Airlie J. McCoy et al.
JOURNAL OF APPLIED CRYSTALLOGRAPHY (2007)
Halogen bonding:: the σ-hole
Timothy Clark et al.
JOURNAL OF MOLECULAR MODELING (2007)
Crystal structure of the hypoxia-inducible form of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase (PFKFB3) - A possible new target for cancer therapy
SG Kim et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Improvements to the throughput of recombinant protein expression in the baculovirus/insect cell system
EJ McCall et al.
PROTEIN EXPRESSION AND PURIFICATION (2005)
Coot:: model-building tools for molecular graphics
P Emsley et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2004)
Is there a difference between leads and drugs? A historical perspective
TI Oprea et al.
JOURNAL OF CHEMICAL INFORMATION AND COMPUTER SCIENCES (2001)
Share Paper
